Are NICE’s current methods for assessing cost-effectiveness ‘fit for purpose’ for the appraisal of regenerative medicines?

Research output: Contribution to conferencePoster

Author(s)

Department/unit(s)

Conference

ConferenceHealth Economics Study Group (HESG)
CountryUnited Kingdom
CityManchester
Conference date(s)3/01/166/01/16

Publication details

DatePublished - 4 Jan 2016
Original languageEnglish

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations